BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu JL, Cheng Y, Xu ZL, Qian GX, Wei MT, Jia WD. Immune checkpoint inhibitors plus anti-angiogenesis in patients with resected high-risk hepatitis B virus-associated hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(4): 101371 [PMID: 40235869 DOI: 10.4251/wjgo.v17.i4.101371]
URL: https://www.wjgnet.com/1948-5204/full/v17/i4/101371.htm
Number Citing Articles
1
Arunkumar Krishnan, Diptasree Mukherjee. Postoperative immune checkpoint inhibitors plus anti-angiogenesis for hepatitis B virus-associated hepatocellular carcinoma: Analyzing the evidence and future prospectsWorld Journal of Gastrointestinal Oncology 2025; 17(9): 106801 doi: 10.4251/wjgo.v17.i9.106801